Pharmaceuticals, Biotechnology and Life Sciences
Pertinax Pharma has appointed Nigel Brooksby as chairman of the company. His main task will be the commercialisation of Pertinax,…
Eli Lilly has reported new data showing that treatment with FORTEO for 24 months was associated with significantly fewer vertebral and clinical…
Sanofi will develop Principia Biopharma`s experimental oral treatment that could tackle multiple sclerosis (MS) and, maybe other central nervous system…
Bavarian Nordic has started the Phase 2 extension study of MVA-BN RSV, a universal vaccine candidate designed to elicit a broad…
Novartis on Wednesday announced positive topline results from the global MONALEESA-7 trial, the second Phase III trial of Kisqali in…
Diplomat Pharmacy, has entered into a definitive agreement to acquire Pharmaceutical Technologies, doing business as National Pharmaceutical Services. The transaction…
Novartis on Monday said that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for…
TiGenix NV has converted €7 million of its senior unsecured convertible bonds due 2018. The company said that, through this…
Novartis, Amgen and the Banner Alzheimer’s Institute (BAI) on Thursday revealed expanding collaboration to initiate a new trial on the…
Boehringer Ingelheim and Dicerna Pharmaceuticals have announced a research collaboration and license agreement to discover and develop novel GalXC RNAi…